Search

everythinglearnresearchcommunity

for

Search:↓

HBM-based nursing intervention improved medication compliance, reduced negative emotions, and enhanced quality of life for renal transplant recipients.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

A diabetes-informed approach is essential for safe and effective skin rejuvenation treatments in diabetics.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

The combined therapy improved symptoms in PCOS patients.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Avicennia marina extract may help treat hair loss naturally.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Altered lipid pathways in diabetic women may cause premature greying.

Combining plant extracts with nanotechnology may improve hair loss treatments.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.